Premium
Creating a transatlantic research enterprise for preventing Alzheimer's disease
Author(s) -
Khachaturian Zaven S.,
Camí Jordi,
Andrieu Sandrine,
Avila Jesús,
Boada Rovira Mercè,
Breteler Monique,
Froelich Lutz,
Gauthier Serge,
GómezIsla Teresa,
Khachaturian Ara S.,
Kuller Lewis H.,
Larson Eric B.,
Lopez Oscar L.,
MartinezLage José Manuel,
Petersen Ronald C.,
Schellenberg Gerard D.,
Sunyer Jordi,
Vellas Bruno,
Bain Lisa J.
Publication year - 2009
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2009.05.158
Subject(s) - standardization , operability , identification (biology) , key (lock) , political science , european union , brain research , business , medicine , knowledge management , public relations , engineering , psychology , computer science , computer security , neuroscience , international trade , botany , law , reliability engineering , biology
In recognition of the global problem posed by Alzheimer's disease and other dementias, an international think‐tank meeting was convened by Biocat, the Pasqual Maragall Foundation, and the Lou Ruvo Brain Institute in February 2009. The meeting initiated the planning of a European Union‐North American collaborative research enterprise to expedite the delay and ultimate prevention of dementing disorders. The key aim is to build parallel and complementary research infrastructure that will support international standardization and inter‐operability among researchers in both continents. The meeting identified major challenges, opportunities for research resources and support, integration with ongoing efforts, and identification of key domains to influence the design and administration of the enterprise.